Top Markets
Coin of the day
Syngen Biotech Co.,Ltd. Syngen Biotech Co.,Ltd.

Syngen Biotech Co.,Ltd.

8279
Classement en actions #23466
Established in 1988 and based in Tainan City, Taiwan, Syngen Biotech Co.,Ltd.... Established in 1988 and based in Tainan City, Taiwan, Syngen Biotech Co.,Ltd. operates globally, including in Taiwan and China, specializing in the research, development, production, and sale of a diverse array of products. Its core offerings include microbial pharmaceutical raw materials, biological pesticides, fertilizers, biochemical nutritional products, and preventive medicines. The company further manufactures dietary supplements and provides comprehensive contract manufacturing services for supplements, accommodating various formats such as sachets, liquids, tablets, cup package capsules, jellies, aluminum and glass bottles, and gummies. Syngen Biotech also develops and markets science-backed bioactive pharmaceutical ingredients (APIs) under proprietary brands including Oraltics, IMMUPHYLA, V3, ST4SanTex, GUARDSPO, benefiGANO, EXPUNERGY, and BIOJOVIAL. Additional services encompass private labelling, organic food OEM/ODM, explosion-proof extraction, brand agency, and wholesale distribution. Syngen Biotech caters to numerous industries, such as sport nutrition, beauty enhancement, baby and mother care, weight management, and digestion and detox. The company actively exports its products to approximately 20 countries worldwide.
Prix de l'action
$2.70
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$73.25M
Changement (1 jour)
0.24%
Changement (1 an)
-34.30%
Pays
TW
Échange Syngen Biotech Co.,Ltd. (8279)

Catégorie

Le prix 8279 avec la capitalisation boursière de B
Syngen Biotech Co.,Ltd. Syngen Biotech Co.,Ltd.
8279
$2.70
Capitalisation boursière de Syngen Biotech Co.,Ltd.(8279)
Capitalisation boursière: $73.25M
En August 2026, Syngen Biotech Co.,Ltd. a une capitalisation boursière de $73.25M. Cela fait de Syngen Biotech Co.,Ltd. la 23466th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Syngen Biotech Co.,Ltd. du 2014 au 2026
8279 par rapport au top 5 des plus populaires stocks
Prix pour 8279 L’actif B La capitalisation boursière de B Résultats
Syngen Biotech Co.,Ltd. Syngen Biotech Co.,Ltd.
$192,295 $73.25M
$5.211T +7,114,254.90%
Syngen Biotech Co.,Ltd. Syngen Biotech Co.,Ltd.
$167,771 $73.25M
$4.547T +6,206,937.97%
Syngen Biotech Co.,Ltd. Syngen Biotech Co.,Ltd.
$153,592 $73.25M
$4.162T +5,682,347.72%
Syngen Biotech Co.,Ltd. Syngen Biotech Co.,Ltd.
$132,571 $73.25M
$3.593T +4,904,635.94%
Syngen Biotech Co.,Ltd. Syngen Biotech Co.,Ltd.
$103,054 $73.25M
$2.793T +3,812,594.37%